Dynatronics

Dynatronics EBITDA Growth YoY

Delisted

The Year-over-Year EBITDA Growth of Dynatronics (DYNT) as of Nov 5, 2026 is -8.03 %. In the previous year, Year-over-Year EBITDA Growth was 54.31 % — a change of -114.78% (lower).

EBITDA Growth YoY

-8.03 %

YoY

-114.78%

Last updated:

Year-over-Year EBITDA Growth of Dynatronics is 2025 -8.03 % . Year-over-Year EBITDA Growth of Dynatronics was 2024 54.31 % . It decreases by -114.78% lower compared to the previous year.

The Dynatronics EBITDA Growth YoY history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Growth YoY
Date
EBITDA Growth YoY
Jan 1, 2018
25.70 USD
Jan 1, 2019
36.02 USD
Jan 1, 2020
-251.68 USD
Jan 1, 2021
185.98 USD
Jan 1, 2022
-283.60 USD
Jan 1, 2023
-5.94 USD
Jan 1, 2024
54.31 USD
Jan 1, 2025
-8.03 USD
The Dynatronics EBITDA Growth YoY history
YEAREBITDA Growth YoYYoY
-8.03 %-114.78%
54.31 %-1,013.76%
-5.94 %-97.90%
-283.60 %-252.49%
185.98 %-173.89%
-251.68 %-798.76%
36.02 %+40.16%
25.70 %+6,937.32%
0.37 %-100.67%
-54.62 %-88.74%
-485.02 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dynatronics Stock analysis

What does Dynatronics do? Dynatronics Corp generates revenue through the sale of medical equipment and supplies for physical therapy and rehabilitation. The company offers therapeutic modalities like Dynatron Solaris for electrotherapy and thermal therapy, and the 25 Series for electrotherapy and ultrasound. It also sells manufactured capital products such as traction systems and wood furniture, along with distributed capital products including hydrotherapy and weight training equipment. Physical therapists, chiropractors, sports medicine practitioners, podiatrists, and physicians purchase these products for use in their practices. The firm's product portfolio includes manufactured supplies like cold packs, straps, wedges, bolsters, and mats, as well as distributed supplies such as clinical accessories, sports med products, taping items, lotions, and gels. These items are sold to healthcare professionals who require daily treatment tools for patient care. Dynatronics Corp targets physical medicine professionals across multiple segments, including orthopedics, pain management, and athletic training, ensuring a steady demand for its comprehensive range of therapeutic solutions. Revenue streams are derived from both direct sales of equipment and ongoing supply purchases. The company's focus on restorative products for physical therapy, rehabilitation, and athletic training positions it as a key provider for healthcare professionals seeking reliable and specialized medical tools. Its diverse product lines cater to the specific needs of practitioners in various physical medicine fields. Dynatronics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Dynatronics stock

Year-over-Year EBITDA Growth of Dynatronics is -8.03 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year EBITDA Growth Dynatronics since 2006 – with annual values, charts, and detailed analysis.

EBITDA growth measures the percentage change in EBITDA compared to the prior year. It shows changes in operating cash earnings before capital structure effects.

To evaluate Year-over-Year EBITDA Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBITDA Growth.

Year-over-Year EBITDA Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBITDA Growth's Dynatronics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Dynatronics

All Key Metrics — Dynatronics